Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8537730 | 0.89 | ALDH1A1 (0.38) | ALDH1A1PKMHDAC3HDAC4HDAC1 | |
| SCHEMBL25267755 | 0.73 | ALDH1A1 (0.39) | ALDH1A1PKMLMNACA12CA1 | |
| SCHEMBL25267754 | 0.73 | ALDH1A1 (0.39) | ALDH1A1PKMLMNACA12CA1 | |
| SCHEMBL1333228 | 0.72 | ALDH1A1 (0.56) | ALDH1A1PKMCYP1A2CYP2C19HDAC3 | |
| SCHEMBL631270 | 0.72 | ALDH1A1 (0.56) | ALDH1A1PKMCYP1A2CYP2C19HDAC3 | |
| SCHEMBL21820033 | 0.70 | LMNA (0.41) | ALDH1A1PKMCYP1A2CYP2C19LMNA | |
| SCHEMBL1226562 | 0.69 | ALDH1A1 (0.54) | ALDH1A1PKMCYP1A2CYP2C19LMNA | |
| SCHEMBL106484 | 0.69 | ALDH1A1 (0.42) | ALDH1A1PKMLMNAHDAC3HDAC4 | |
| Ethylene Glycol SCHEMBL29002151 | 0.68 | ALDH1A1 (0.51) | ALDH1A1PKMCYP1A2CYP2C19HDAC3 | |
| SCHEMBL14674752 | 0.66 | ALDH1A1 (0.50) | ALDH1A1PKMCYP1A2CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0512074-B1 | MOLECULES WITH ANTIBODY COMBINING SITES THAT CATALYSE HYDROLYSIS REACTIONS | SCRIPPS RESEARCH INST (US) | 1998-07-22 | — | — | EP | disclosed |
| EP-0666905-A4 | MOLECULES WITH ANTIBODY COMBINING SITES THAT INDUCE ASYMMETRY. | SCRIPPS RESEARCH INST (US) | 1996-07-24 | — | — | EP | disclosed |
| US-5444155-A | Paratope-containing; immunoreact with a meso diester substrate ligand and catalytically hydrolyze a single predetermined ester bond to form one of a pair of enantiomers | THE SCRIPPS RESEARCH INSTITUTE (US) | 1995-08-22 | — | — | US | disclosed |
| EP-0666905-A1 | MOLECULES WITH ANTIBODY COMBINING SITES THAT INDUCE ASYMMETRY | THE SCRIPPS RESEARCH INSTITUTE (US) | 1995-08-16 | — | — | EP | disclosed |
| EP-0454778-A4 | MOLECULES WITH ANTIBODY COMBINING SITES THAT EXHIBIT STEREOSPECIFIC CATALYSIS | — | 1993-10-06 | — | — | EP | disclosed |
| US-5250426-A | Catalytic hydrolysis using monoclonal antibodies | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-10-05 | — | — | US | disclosed |
| US-5248611-A | ENANTIOMORPHS | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1993-09-28 | — | — | US | disclosed |
| EP-0512074-A4 | MOLECULES WITH ANTIBODY COMBINING SITES THAT CATALYSE HYDROLYSIS REACTIONS | — | 1993-07-14 | — | — | EP | disclosed |
| EP-0260939-B1 | MOLECULES WITH ANTIBODY COMBINING SITES THAT EXHIBIT CATALYTIC PROPERTIES | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1993-04-28 | — | — | EP | disclosed |
| WO-1993005146-A1 | MOLECULES WITH ANTIBODY COMBINING SITES THAT INDUCE ASYMMETRY | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-03-18 | — | — | WO | disclosed |
| US-5126258-A | Hydrolysis of polypeptides at predetermined site | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1992-06-30 | — | — | US | disclosed |
| US-5079152-A | ANTIBODY COMBINING SITES THAT EXHIBIT STEREOSELECTIVE SYNTHASE ACTIVITY, AND METHODS USING THE SAME | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1992-01-07 | — | — | US | disclosed |
| EP-0454778-A1 | MOLECULES WITH ANTIBODY COMBINING SITES THAT EXHIBIT STEREOSPECIFIC CATALYSIS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1991-11-06 | — | — | EP | disclosed |
| WO-1991011512-A1 | MOLECULES WITH ANTIBODY COMBINING SITES THAT CATALYSE HYDROLYSIS REACTIONS | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1991-08-08 | — | — | WO | disclosed |
| US-5030717-A | Binding site which bind to reactant ligand, stabilization | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1991-07-09 | — | — | US | disclosed |
| EP-0315680-A4 | ANTIBODY COMBINING SITES THAT EXHIBIT STEREOSELECTIVE SYNTHASE ACTIVITY, AND METHODS USING THE SAME | — | 1990-09-19 | — | — | EP | disclosed |
| US-4900674-A | Antibody combining sites that exhibit amide or ester synthase activity | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-02-13 | — | — | US | disclosed |
| EP-0315680-A1 | ANTIBODY COMBINING SITES THAT EXHIBIT STEREOSELECTIVE SYNTHASE ACTIVITY, AND METHODS USING THE SAME | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-05-17 | — | — | EP | disclosed |
| WO-1988009380-A1 | ANTIBODY COMBINING SITES THAT EXHIBIT STEREOSELECTIVE SYNTHASE ACTIVITY, AND METHODS USING THE SAME | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1988-12-01 | — | — | WO | disclosed |
| EP-0260939-A2 | Molecules with antibody combining sites that exhibit catalytic properties | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1988-03-23 | — | — | EP | disclosed |